Stamford Pharmaceuticals is a clinical stage immunology and inflammation-focused company developing gene therapies and biologics. It provides a range of medicines to treat basal cell nevus syndrome, basal cell carcinomas, cutaneous squamous cell carcinomas, and cancers.